🇫🇷
France · FR · FR:68722564
TYSABRI 300 mg, solution à diluer pour perfusion
ATC L04AG03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBIOGEN NETHERLANDS (PAYS-BAS)
CountryFR (France)
ATC codeL04AG03
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009569967731 flacon(s) en verre de 15 ml
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "68722564",
"date_amm": "2006-06-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/06/346",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L04AG03.
Access this data programmatically
Query TYSABRI 300 mg, solution à diluer pour perfusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.